Environmental

Smith & Nephew’s R&D intensity near 4.8% of revenue supports product innovation and lower-obsolescence risk versus slower-investing medtech peers.

The company’s capital allocation appears disciplined, but the provided metrics do not evidence a peer-leading environmental footprint or decarbonization advantage.

No direct emissions, energy, water, or waste disclosures were provided, limiting confidence that environmental management materially exceeds diversified medtech peers.

Relative to peers, the main environmental strength is innovation-led product design, while the absence of disclosed operational sustainability metrics keeps the profile below top-tier leaders.

Social

Smith & Nephew’s medical-device focus makes product safety and clinical performance material, and sustained R&D spending supports peer-competitive patient and surgeon outcomes.

The absence of stock-based compensation in the provided metrics suggests lower pay-related dilution pressure, which can support workforce alignment versus peers with heavier equity incentives.

No controversy, labor, or supply-chain incident data were provided, so the social assessment relies on structural factors rather than confirmed peer-leading practices.

Relative to peers, the company appears solid on product responsibility and stakeholder alignment, but the evidence base is insufficient to justify an exceptional social score.

Governance

Debt-to-equity of 0.73 and net debt-to-EBITDA of 1.84 indicate moderate leverage, which generally supports governance discipline versus more highly levered medtech peers.

Zero stock-based compensation in the provided metrics suggests a cleaner incentive structure and lower dilution risk than peers with more aggressive equity compensation.

The metrics do not reveal board independence, audit quality, or controversy history, so the governance view is anchored mainly on capital discipline and leverage.

Relative to peers, governance looks sound rather than leading, because the available evidence shows restraint but not a clearly superior oversight framework.

Overall Score

SNN screens as a strong ESG name versus peers, led by disciplined capital structure and innovation-linked stakeholder benefits, while limited disclosure prevents a higher score.

Score Driver: Moderate Leverage Combined With Disciplined Incentive Structure